On October 29, 2026, a new publication titled "Metal Hypersensitivity After Cardiovascular Device Implantation Presenting With Refractory Urticaria and Angioedema" appeared in JACC: Case Reports. The publication is indexed under PubMed ID 42955043. Bradykinin is referenced in connection with this case report, which remains classified as unapproved research. No findings, outcomes, or conclusions from the publication are detailed here beyond its title and placement in the journal. The report is cataloged as a case study format within JACC: Case Reports, a publication associated with the American College of Cardiology. As with any newly indexed publication, readers interested in the specific content, methodology, or clinical details should consult the full text directly through the source link. This brief serves only to note the existence and timing of the publication, not to summarize its content or implications. Bradykinin's regulatory status remains unapproved for clinical use outside of research settings. For additional background on bradykinin, including its general research context and current regulatory standing, readers can consult the compound overview.
Bradykinin-Related Case Study Published in JACC: Case Reports
See the full bradykinin overview
Source: https://pubmed.ncbi.nlm.nih.gov/42955043/